Characterization of Anthrax Lethal Toxin
炭疽致命毒素的表征
基本信息
- 批准号:7345645
- 负责人:
- 金额:$ 26.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAnimalsAnthrax diseaseAntigensApoptosisBacillus anthracisBacteriaCaspaseCell DeathCell physiologyCellsCessation of lifeCleaved cellCytosolDiseaseElementsEndopeptidasesEndothelial CellsEpitopesFluorescent Antibody TechniqueFractionationGoalsHumanImmuneImmune systemImpairmentIndiumIndividualInjection of therapeutic agentInterleukin-8MAP2K1 geneMammalian CellMediatingMessenger RNAMitogen-Activated Protein Kinase KinasesMolecularNumbersPathogenesisPathologyPatientsPeptide HydrolasesPharmaceutical PreparationsPredispositionProcessPropertyProtein BindingProteinsRegulationResearchResearch PersonnelResistanceSymptomsThinkingToxinTranscriptVirulence FactorsWorkZincanthrax lethal factorantigen bindingcell typecytokinegenetic regulatory proteinhuman MAP2K1 proteinkillingsmRNA Stabilitymacrophagemutanttherapeutic target
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this application is to elucidate mechanisms by which anthrax lethal toxin contributes to the disease process. Lethal toxin is an essential virulence factor that allows Bacillus anthracis to colonize and kill the host. Furthermore, damage caused by lethal toxin is likely a contributing factor to the long-term pathologies displayed by surviving patients. It is critical, therefore, to gain a better understanding of how the toxin interacts with the host. Lethal factor is the enzymatic component of the toxin that cleaves mitogen activated protein kinase kinases after being delivered to the mammalian cell cytosol by the second toxin component, protective antigen. How lethal factor's enzymatic activity causes the cellular effects associated with the toxin is poorly understood. The first aim of this proposal is to determine how lethal toxin interferes with cvtokine expression. We have discovered that lethal toxin destabilizes interleukin-8 mRNA in primary human endothelial cells. It has been shown that many transcripts are post-transcriptionally regulated by specific elements in their 3' untranslated regions and by the proteins that bind these regions. We will identify regulatory proteins and mRNA elements that are targeted by lethal toxin action; and identify other transcripts that are destabilized by the toxin. Our second aim is to determine how and why lethal toxin induces caspase-independent programmed cell death in human macrophages, but not in the immature monocvtes from which they were derived. We will use a combination of cellular fractionation and immunofluorescence techniques to identify proteins that mediate cell death; and compare toxin-sensitive and resistant cells to determine cellular properties that confer susceptibility to lethal toxin. Our final aim is to isolate lethal factor mutants that can cleave some of its substrates, but not others, so that the contributions of individual substrates to pathogenic processes can be assessed. To accomplish this, we will screen random lethal factor mutants for ones that are able to kill some cell types, but not others. This work will potentially identify new substrate binding determinants that could be targeted by therapeutics.
Relevance: The goal of our research is to understand how anthrax lethal toxin damages human cells. A better understanding of how the toxin works will help doctors treat patients with anthrax and help researchers discover new drug treatments.
描述(由申请人提供):本申请的总体目标是阐明炭疽致死毒素促进疾病过程的机制。致死毒素是炭疽杆菌在宿主体内定植和致死的重要毒力因子。此外,致命毒素造成的损伤可能是存活患者表现出长期病理的一个促成因素。因此,更好地了解毒素如何与宿主相互作用至关重要。致死因子是毒素的酶组分,其在通过第二毒素组分(保护性抗原)递送至哺乳动物细胞胞质溶胶后切割促分裂原活化的蛋白激酶激酶。致死因子的酶活性如何引起与毒素相关的细胞效应还知之甚少。该提议的第一个目的是确定致死毒素如何干扰cvtokine表达。我们已经发现,致命毒素不稳定的白细胞介素-8 mRNA在原代人内皮细胞。已经表明,许多转录物在转录后由其3'非翻译区中的特定元件和结合这些区域的蛋白质调节。我们将确定致命毒素作用靶向的调节蛋白和mRNA元件,并确定毒素不稳定的其他转录本。我们的第二个目标是确定致命毒素如何以及为什么在人类巨噬细胞中诱导半胱天冬酶非依赖性程序性细胞死亡,而不是在它们所来源的未成熟单核细胞中。我们将使用细胞分级分离和免疫荧光技术相结合,以确定介导细胞死亡的蛋白质,并比较毒素敏感和耐药细胞,以确定细胞特性,赋予致命毒素的敏感性。我们的最终目标是分离出可以切割其某些底物而不能切割其他底物的致死因子突变体,以便可以评估单个底物对致病过程的贡献。为了实现这一目标,我们将筛选随机致死因子突变体,以寻找能够杀死某些细胞类型但不能杀死其他细胞类型的突变体。这项工作将有可能确定新的底物结合决定簇,可以通过治疗靶向。
相关性:我们研究的目的是了解炭疽致命毒素如何损害人体细胞。更好地了解这种毒素是如何起作用的,将有助于医生治疗炭疽病患者,并有助于研究人员发现新的药物治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEREMY S MOGRIDGE其他文献
JEREMY S MOGRIDGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEREMY S MOGRIDGE', 18)}}的其他基金
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
- 批准号:
7046921 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
- 批准号:
6874924 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
Development and testing of polyvalent anthrax toxin inhibitors
多价炭疽毒素抑制剂的开发和测试
- 批准号:
7455423 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
Development and testing of polyvalent anthrax toxin inhibitors
多价炭疽毒素抑制剂的开发和测试
- 批准号:
7936885 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
Development and testing of anthrax toxin inhibitors
炭疽毒素抑制剂的开发和测试
- 批准号:
6806450 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
Development and testing of polyvalent anthrax toxin inhibitors
多价炭疽毒素抑制剂的开发和测试
- 批准号:
8137209 - 财政年份:2003
- 资助金额:
$ 26.22万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 26.22万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 26.22万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 26.22万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 26.22万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 26.22万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 26.22万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 26.22万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 26.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 26.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 26.22万 - 项目类别:














{{item.name}}会员




